Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells

aDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University

bMedicine, Virginia Commonwealth University, Richmond Virgina

cDepartment of Integrative Biology and Pharmacology, McGoven Medical School, University of Texas Health Science Center, Houston, Texas, USA

Received 4 August 2022 Revised form accepted 8 September 2022.

Correspondence to Paul Dent, PhD, Department of Biochemistry and Molecular Biology, Massey Cancer Center, Box 980035, Virginia Commonwealth University, Richmond, VA 23298-0035, USA, Tel: +804 539 2582; e-mail: [email protected]

留言 (0)

沒有登入
gif